Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,931 | 119 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $295.49 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $213.83 | 16 | $0 (2024) |
| Amgen Inc. | $209.75 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $168.61 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $162.23 | 8 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $147.21 | 11 | $0 (2018) |
| Novo Nordisk Inc | $137.91 | 9 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $135.77 | 9 | $0 (2018) |
| GENZYME CORPORATION | $43.88 | 2 | $0 (2019) |
| Horizon Therapeutics plc | $42.78 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $280.76 | 14 | ABBVIE INC. ($69.37) |
| 2023 | $310.80 | 16 | AbbVie Inc. ($104.99) |
| 2022 | $204.86 | 12 | ABBVIE INC. ($66.95) |
| 2021 | $238.48 | 15 | AbbVie Inc. ($54.18) |
| 2020 | $163.67 | 12 | GlaxoSmithKline, LLC. ($39.38) |
| 2019 | $218.37 | 14 | AstraZeneca Pharmaceuticals LP ($46.74) |
| 2018 | $190.73 | 13 | Amgen Inc. ($56.97) |
| 2017 | $323.63 | 23 | Sunovion Pharmaceuticals Inc. ($122.74) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: Biological | ||||||
| 09/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Bone Health | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Bone Health | ||||||
| 05/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: PAIN | ||||||
| 10/10/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: PAIN | ||||||
| 09/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: Biological | ||||||
| 09/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: INSOMNIA | ||||||
| 07/19/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Bone Health | ||||||
| 06/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: General - Pain Management_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,217 | 1,584 | $106,245 | $33,813 |
| 2022 | 24 | 2,000 | 2,662 | $182,583 | $64,363 |
| 2021 | 26 | 2,197 | 3,100 | $196,333 | $71,804 |
| 2020 | 31 | 3,350 | 4,417 | $292,510 | $97,853 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 116 | $27,550 | $8,108 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $14,710 | $7,252 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 98 | $16,920 | $5,557 | 32.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 87 | 91 | $5,096 | $1,498 | 29.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 48 | $4,960 | $1,479 | 29.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 97 | 118 | $4,838 | $1,221 | 25.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 114 | 142 | $1,420 | $1,193 | 84.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 79 | 84 | $4,872 | $1,102 | 22.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 103 | 128 | $3,584 | $966.51 | 27.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 81 | 94 | $4,230 | $894.88 | 21.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 87 | 91 | $3,822 | $804.44 | 21.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,300 | $736.32 | 56.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 69 | $3,105 | $650.78 | 21.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 35 | 35 | $2,240 | $643.28 | 28.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 109 | 126 | $1,512 | $426.25 | 28.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 19 | 19 | $475.00 | $388.74 | 81.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 19 | $1,501 | $376.69 | 25.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 51 | 56 | $2,688 | $316.96 | 11.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 100 | $600.00 | $81.35 | 13.6% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 16 | 16 | $352.00 | $66.88 | 19.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 47 | $470.00 | $50.54 | 10.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 241 | $50,110 | $19,229 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 200 | $30,450 | $12,208 | 40.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 85 | 85 | $18,721 | $10,277 | 54.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 138 | 161 | $9,016 | $2,668 | 29.6% |
About Dr. Reed Ward, DO
Dr. Reed Ward, DO is a Family Medicine healthcare provider based in Idaho Falls, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235217506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reed Ward, DO has received a total of $1,931 in payments from pharmaceutical and medical device companies, with $280.76 received in 2024. These payments were reported across 119 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($1,931).
As a Medicare-enrolled provider, Ward has provided services to 8,764 Medicare beneficiaries, totaling 11,763 services with total Medicare billing of $267,832. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Idaho Falls, ID
- Active Since 11/02/2006
- Last Updated 09/15/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235217506
Products in Payments
- FARXIGA (Drug) $182.48
- UBRELVY (Drug) $134.51
- EVENITY (Biological) $130.56
- VRAYLAR (Drug) $106.83
- TOUJEO (Drug) $75.00
- Veozah (Drug) $67.38
- LATUDA (Drug) $62.79
- MYRBETRIQ (Drug) $61.02
- SOLIQUA (Drug) $60.77
- QULIPTA (Drug) $54.15
- TRELEGY ELLIPTA (Drug) $47.46
- Rybelsus (Drug) $47.23
- Ozempic (Drug) $44.22
- AUBAGIO (Drug) $43.88
- KRYSTEXXA (Biological) $42.78
- BEXSERO (Biological) $41.41
- ANORO ELLIPTA (Drug) $39.21
- Prolia (Biological) $36.62
- UTIBRON (Drug) $36.59
- Myrbetriq (Drug) $33.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Idaho Falls
Anne Broadway, M.d, M.D
Family Medicine — Payments: $184,631
Dr. Julian De Bruyn Kops, Md, MD
Family Medicine — Payments: $93,443
Wallace Baker, M.d, M.D
Family Medicine — Payments: $13,901
Dr. Flint Packer, D.o, D.O
Family Medicine — Payments: $12,258
Dr. Boyd Southwick, Do, DO
Family Medicine — Payments: $11,879
Dr. Barry Bennett, Md, MD
Family Medicine — Payments: $11,296